hotspot -WSS

hotspot

author：focus 2025-09-06 08:39:36 - browse：21

Adobe

At least 224 diabetes patients have been harmed by a software error causing their insulin pumps to spontaneously shut down, the Food and Drug Administration announced in a recall notice on Wednesday.

The product is made by Tandem Diabetes Care, which sells touchscreen insulin pumps and an accompanying app to help dose the medicine. Around 300,000 people use the technology. Tandem found that a bug in the app’s software is causing the app to repeatedly crash and relaunch, draining the insulin pump’s battery through unnecessary Bluetooth communication.

An insulin pump shutting down unexpectedly could kill people, especially if the shutdown occurs while the person is sleeping. There have been no reports of death so far, the FDA said. Tandem users commiserated over the issue on Reddit two months ago, with one user describing waking up at 2 a.m. to a dead pump. “Infuriating,” the user wrote. “Absolutely should be sending a notice out to all customers about this.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Syphilis numbers in the United States reach record heights

explore

WSS

Syphilis numbers in the United States reach record heights

Merck, Johnson & Johnson CEOs will testify on high drug prices

Sage hopes for a blockbuster in antidepressant now before FDA

Zyn nicotine pouches become unlikely player in latest culture war

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

explore

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Wikipedia

BioMarin wins approval for gene therapy to treat hemophilia A

Zyn nicotine pouches become unlikely player in latest culture war

Hollywood unions extend contract negotiations for actors

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Bright Health sells Medicare Advantage business to Molina

Philips to halt sales of sleep apnea machines in U.S.

Medical leaders decry Supreme Court decision on affirmative action

The high personal cost of affirmative action for Black doctors

DIEP, the 'gold standard' of breast reconstruction, is under threat

Boston competes with Raleigh

focus

Venture capital firm's plans to take over Akron hospital face hurdles

NIH launches clinical trials and new research office for long Covid

Sage hopes for a blockbuster in antidepressant now before FDA

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Merck CEO won’t testify in Senate, citing no expertise in drug prices

New safety details link Apellis eye drug to rare cases of blindness

knowledge

explore

focus

knowledge